Lyell Immunopharma (LYEL) Treasury Shares (2020 - 2021)

Lyell Immunopharma has reported Treasury Shares for 7 years, with the latest figure at $36398.0 in Q1 2026.

• Quarterly Treasury Shares fell 99.6% year-over-year to $36398.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $36398.0 (down 99.6% YoY) and the FY2025 annual result came in at $306415.0, up 126.69% from the prior year.
• Treasury Shares retreated to $36398.0 in Q1 2026 per LYEL's latest filing, from $306415.0 in the prior quarter.
• Over five years, Treasury Shares peaked at $9.1 million in Q1 2025 and troughed at $36398.0 in Q1 2026.
• A 5-year average of $2.2 million and a median of $1.4 million in 2022 frame the typical range for Treasury Shares.
• The sharpest annual moves came in 2025 and 2026: Treasury Shares soared 236.81% in 2025, then sank 99.6% in 2026.
• Over 5 years, Treasury Shares stood at $872077.0 in 2022, then jumped by 218.44% to $2.8 million in 2023, then tumbled by 95.13% to $135170.0 in 2024, then surged by 126.69% to $306415.0 in 2025, then tumbled by 88.12% to $36398.0 in 2026.
• According to Business Quant data, Treasury Shares over the past three periods registered $36398.0, $306415.0, and $84047.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.